Human neutrophil elastase inhibitory alkaloids from chelidonium majus Lopen access
- Authors
- Kim, J.Y.; Lee, J.H.; Song, Y.H.; Jeong, W.M.; Tan, X.; Uddin, Z.; Park, K.H.
- Issue Date
- 2015
- Publisher
- Korean Society for Applied Biological Chemistry
- Keywords
- Chelidonium majus L; Human neutrophil elastase; Inflammation; Isoquinoline alkaloid
- Citation
- Journal of Applied Biological Chemistry, v.58, no.3, pp 281 - 285
- Pages
- 5
- Indexed
- SCOPUS
KCI
- Journal Title
- Journal of Applied Biological Chemistry
- Volume
- 58
- Number
- 3
- Start Page
- 281
- End Page
- 285
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/18477
- DOI
- 10.3839/jabc.2015.044
- ISSN
- 1976-0442
2234-7941
- Abstract
- Human neutrophil elastase (HNE) represents a good therapeutic target for the treatment of inflammatory diseases as well as invasion of microorganism. The methanol extract of a aerial part of Chelidonium majus L. showed high activity against the neutrophil elastase with an IC50 value of 100 μg/mL. Due to its potency, subsequent bioactivity-guided fractionation of methanol extract led to six alkaloids (1-6), which were identified as dihydrosanguinarine (1), (s)-stylopine (2), arnottianamide (3), (+)-chelidonine (4), spallidamine (5), and N-transferuloyltyramine (6). Among of them, three alkaloids (2, 5, and 6) inhibited HNE in a dose-dependent manner with IC50 ranging between 11.6 and 51.0 μM. Lineweaver-Burk and Dixon plots, and their secondary replots showed that alkaloids (2, 5, and 6) were mixed inhibitors of HNE. The analysis of KI and KIS value proved that all inhibitors (2, 5, and 6) had reversible mixed type I mechanism. ? The Korean Society for Applied Biological Chemistry 2015.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.